Dataset Viewer
question_key
stringlengths 16
58
| relation
stringlengths 6
48
| question_template
stringlengths 29
90
| subject_cui
stringlengths 8
8
| subject_label
stringlengths 4
160
| correct_object_cui
stringlengths 8
8
| correct_object_label
stringlengths 3
204
| opa
stringlengths 7
150
| opb
stringlengths 3
204
| opc
stringlengths 4
221
| opd
stringlengths 5
166
| cop
int64 0
3
|
---|---|---|---|---|---|---|---|---|---|---|---|
C5396085::active_ingredient_of | active_ingredient_of | Which of the following has {subj} as an active ingredient? | C5396085 | Inactivated whole Human poliovirus antigen | C5548580 | Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens only vaccine product | Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine | Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens only vaccine product | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B | 1 |
C0017628::active_ingredient_of | active_ingredient_of | Which of the following has {subj} as an active ingredient? | C0017628 | glyburide | C0939773 | glyburide / metformin | glyburide / metformin | metformin / ropinirole | clopamide / reserpine | phenformin and sulfonylureas | 0 |
C0145106::active_ingredient_of | active_ingredient_of | Which of the following has {subj} as an active ingredient? | C0145106 | teicoplanin | C4754944 | Teicoplanin only product | Teicoplanin only product | metronidazole / scopolamine | bifonazole, combinations | fluocinolone acetonide and antibiotics | 0 |
C0725616::active_moiety_of | active_moiety_of | Which of the following has {subj} as its active moiety? | C0725616 | citric acid, anhydrous | C0376734 | ACD-A solution | Efasin-HD | MSP-Blu | ACD-A solution | E-Z-CAT | 2 |
C0085149::active_moiety_of | active_moiety_of | Which of the following has {subj} as its active moiety? | C0085149 | tacrolimus | C5221552 | TACROLIMUS 1 g in 1 g NOT APPLICABLE POWDER | HEPARIN SODIUM (BEEF LUNG) | FORMALDEHYDE/ISOPROPYL ALCOHOL/SODIUM NITRITE | MORPHINE SULFATE PWDR | TACROLIMUS 1 g in 1 g NOT APPLICABLE POWDER | 3 |
C0059374::active_moiety_of | active_moiety_of | Which of the following has {subj} as its active moiety? | C0059374 | enrofloxacin | C4283200 | ENROFLOXACIN 24.75 kg in 25 kg NOT APPLICABLE POWDER [X] | SODIUM CHLORIDE/VINBLASTINE | ALLERGENIC EXTRACT, ELM, CHINESE & AMERICAN, POLLEN MIX | LANSOPRAZOLE 3MG/ML SUSP,ORAL | ENROFLOXACIN 24.75 kg in 25 kg NOT APPLICABLE POWDER [X] | 3 |
C0448161::anatomic_structure_is_physical_part_of | anatomic_structure_is_physical_part_of | Which anatomic structure is {subj} physically part of? | C0448161 | Structure of shaft of rib | C0037253 | Skeletal system | Axial skeletal system | Skeletal system of upper limb | Skeletal system.peripheral | Skeletal system | 3 |
C1520699::anatomic_structure_is_physical_part_of | anatomic_structure_is_physical_part_of | Which anatomic structure is {subj} physically part of? | C1520699 | 16q22-q23 | C1520690 | 16q | SCA10 gene.CAG repeats | 16q | End Chromosome Band | Chromosome 13 Short Arm | 1 |
C1520356::anatomic_structure_is_physical_part_of | anatomic_structure_is_physical_part_of | Which anatomic structure is {subj} physically part of? | C1520356 | 11p11.2-p11.1 | C0007634 | Cells | Stem cells | Cells.ZAP70 | Cells.CD21 | Cells | 3 |
C0925420::articulates_with | articulates_with | Which anatomic structure articulates with {subj}? | C0925420 | Right zygomatic bone | C0037884 | Sphenoid bone structure | Body proper of sphenoid | Structure of clinoid process of sphenoid bone | Sphenoidal crest | Sphenoid bone structure | 3 |
C0925966::articulates_with | articulates_with | Which anatomic structure articulates with {subj}? | C0925966 | Right lacrimal bone | C0015027 | Ethmoid bone structure | Sphenoid bone part | Omohyoid muscle structure | Bone structure of intermediate cuneiform | Ethmoid bone structure | 3 |
C0038293::articulates_with | articulates_with | Which anatomic structure articulates with {subj}? | C0038293 | Sternum | C0502659 | Right first costal cartilage | Left minor alar cartilage | Body of ninth costal cartilage | Right lateral nasal cartilage | Right first costal cartilage | 3 |
C0029927::associated_condition_of | associated_condition_of | For which of the following is {subj} an associated condition? | C0029927 | Ovarian Cysts | C0238015 | Autonomic Dysreflexia | Autonomic Dysreflexia | Autonomic disorder due to metabolic disorder | Diabetic Autonomic Neuropathy | Baroreflex failure syndrome | 0 |
C5848305::associated_condition_of | associated_condition_of | For which of the following is {subj} an associated condition? | C5848305 | Porphyria (disorder) | C4060572 | Chronic functional constipation | Chronic functional constipation | Intermittent dysphagia | Chronic radiation cystitis | Dysfunctional voiding | 0 |
C0008679::associated_condition_of | associated_condition_of | For which of the following is {subj} an associated condition? | C0008679 | Chronic disease | C0812364 | Chronic sorrow | Organic depression | Felt vague | Chronic sorrow | Mental deficiency | 2 |
C0030499::associated_etiologic_finding_of | associated_etiologic_finding_of | For which of the following is {subj} an associated etiologic finding? | C0030499 | Parasitic Diseases | C0409572 | Arthropathy of the ankle and/or foot associated with helminthiasis | Other infectious and parasitic diseases with arthropathy of the pelvic region and thigh | Arthropathy of the ankle and/or foot associated with helminthiasis | Other infectious and parasitic diseases with arthropathy of the lower leg | Other infectious and parasitic diseases with arthropathy of the hand | 1 |
C0011849::associated_etiologic_finding_of | associated_etiologic_finding_of | For which of the following is {subj} an associated etiologic finding? | C0011849 | Diabetes Mellitus | C0271674 | Asymmetric Diabetic Proximal Motor Neuropathy | Chronic Metabolic Polyneuropathy | Spinocerebellar Ataxia with Dysmorphism | Asymmetric Diabetic Proximal Motor Neuropathy | Drug or Chemical Induced Diabetes Mellitus with Neurological Complication with Diabetic Polyneuropathy | 2 |
C1882062::associated_etiologic_finding_of | associated_etiologic_finding_of | For which of the following is {subj} an associated etiologic finding? | C1882062 | Neoplastic disease | C0730308 | Melanoma-Associated Retinopathy | Advanced Uveal Melanoma | Locally Advanced Ocular Melanoma | Uveal Class 2 Melanoma | Melanoma-Associated Retinopathy | 3 |
C0021368::associated_morphology_of | associated_morphology_of | For which of the following is {subj} an associated morphology? | C0021368 | Inflammation | C0267508 | Colitis cystica profunda | Colitis cystica profunda | Condyloma accuminata recurrent | Proctitis fungal | Ulcerative (chronic) pancolitis with fistula | 0 |
C0016665::associated_morphology_of | associated_morphology_of | For which of the following is {subj} an associated morphology? | C0016665 | Fractures, Ununited | C2214361 | nonunion of fracture of base of first metacarpal of right hand | malunion of fracture of shaft of right first metacarpal | malunion of fracture of head of right fourth metacarpal | nonunion of fracture of base of first metacarpal of right hand | malunion of fracture of neck of right fourth metacarpal | 2 |
C0334044::associated_morphology_of | associated_morphology_of | For which of the following is {subj} an associated morphology? | C0334044 | Dysplasia | C0586351 | Mild stomach dysplasia | Meibomian gland dysfunction | Mild stomach dysplasia | Pharyngeal dysplasia | Mild dysostosis multiplex | 1 |
C1148575::biological_process_involves_gene_product | biological_process_involves_gene_product | Which gene product is involved in the biological process of {subj}? | C1148575 | antigen binding | C4331804 | ppUL38 Antibody | ppUL38 Antibody | Titin Ab | LAN Antibody | CD41-Bf Ag | 0 |
C1517880::biological_process_involves_gene_product | biological_process_involves_gene_product | Which gene product is involved in the biological process of {subj}? | C1517880 | Ligand Binding | C1506359 | KLRD1 protein, human | PLEC protein, human | LRRTM2 protein, human | KLRD1 protein, human | AGR3 protein, human | 2 |
C1148673::biological_process_involves_gene_product | biological_process_involves_gene_product | Which gene product is involved in the biological process of {subj}? | C1148673 | DNA Binding | C1506608 | FOXA2 protein, human | FOXA2 protein, human | NPM1 protein, human | MUC5AC protein, human | CDCP1 protein, human | 0 |
C1513112::biological_process_is_part_of_process | biological_process_is_part_of_process | Which larger process is the biological process {subj} a part of? | C1513112 | Membrane Protein Traffic | C1514251 | Post-Translational Regulation | positive regulation of protein autoubiquitination | eIF2 Regulation Pathway | Regulation of Proteolysis | Post-Translational Regulation | 3 |
C1517338::biological_process_is_part_of_process | biological_process_is_part_of_process | Which larger process is the biological process {subj} a part of? | C1517338 | Negative Regulation of G0 to G1 Transition | C1155839 | Mitotic Cell Cycle | Mitotic Cell Cycle | generative cell mitosis | Negative Regulation of Cytolytic Process | Mitotic Spindle Checkpoints | 0 |
C1519473::biological_process_is_part_of_process | biological_process_is_part_of_process | Which larger process is the biological process {subj} a part of? | C1519473 | Spleen Development | C0678723 | biological development | primary sex determination | secondary growth | biological development | infection cushion formation | 2 |
C0505647::branch_of | branch_of | Which of the following is {subj} a branch of? | C0505647 | Muscular branch of lateral branch of posterior ramus of left first thoracic nerve | C0505300 | Lateral branch of posterior ramus of left first thoracic nerve | Lateral branch of posterior ramus of left first thoracic nerve | Lateral cutaneous branch of medial branch of posterior ramus of right first thoracic nerve | Lateral cutaneous branch of medial branch of posterior ramus of right twelfth thoracic nerve | Lateral cutaneous branch of medial branch of posterior ramus of left third thoracic nerve | 0 |
C0923265::branch_of | branch_of | Which of the following is {subj} a branch of? | C0923265 | Right ophthalmic artery | C0226156 | Structure of right internal carotid artery | Structure of right internal carotid artery | Tentorial marginal branch of internal carotid artery | Structure of left cavernous portion of internal carotid artery | Structure of carotid sinus | 0 |
C0226475::branch_of | branch_of | Which of the following is {subj} a branch of? | C0226475 | Structure of left posterior tibial artery | C0226400 | Structure of left external iliac artery | Structure of right iliac vessel | Structure of left external iliac artery | Structure of common iliac vein | Structure of left popliteal vein | 1 |
C0013227::causative_agent_of | causative_agent_of | Which condition is caused by {subj} as an agent? | C0013227 | Pharmaceutical Preparations | C0271805 | Hypothyroidism caused by drug | Hypothyroidism in childbirth | Hypothyroidism due to iodide trapping defect | Severe hypothyroidism | Hypothyroidism caused by drug | 3 |
C0040979::causative_agent_of | causative_agent_of | Which condition is caused by {subj} as an agent? | C0040979 | trifluoperazine | C4075958 | Retinopathy caused by trifluoperazine | Adverse reaction to ipratropium bromide | Adverse reaction to chlortetracycline hydrochloride | Retinopathy caused by trifluoperazine | Adverse reaction to medroxyprogesterone acetate | 2 |
C0022625::causative_agent_of | causative_agent_of | Which condition is caused by {subj} as an agent? | C0022625 | ketoconazole | C0413464 | Ketoconazole adverse reaction | Adverse reaction to promethazine hydrochloride | Adverse reaction to isoprenaline sulphate | Ketoconazole adverse reaction | Adverse reaction to bezafibrate | 2 |
C0277542::cause_of | cause_of | Which of the following is caused by {subj}? | C0277542 | Organic disease present | C4064407 | obsessive-compulsive and related disorder due to another medical condition | alcohol dependence with alcohol-induced psychotic disorder with delusions | Obsessive compulsive disorder caused by stimulant | alcohol abuse with alcohol-induced psychotic disorder with delusions | obsessive-compulsive and related disorder due to another medical condition | 3 |
C4721412::cause_of | cause_of | Which of the following is caused by {subj}? | C4721412 | Malignant Pancreatic Insulinoma | C5229728 | Hyperinsulinemia due to malignant insulinoma | Humoral hypercalcemia of malignancy (disorder) | Adult onset non-insulinoma persistent hyperinsulinemic hypoglycemia | Idiopathic transient neonatal hyperinsulinemia | Hyperinsulinemia due to malignant insulinoma | 3 |
C0009450::cause_of | cause_of | Which of the following is caused by {subj}? | C0009450 | Communicable Diseases | C0409677 | Juvenile reactive arthritis triad | Juvenile pauciarticular chronic arthritis | Juvenile idiopathic arthritis, persistent oligoarthritis | Juvenile polyarteritis | Juvenile reactive arthritis triad | 3 |
C0039195::cell_type_or_tissue_affected_by_chemical_or_drug | cell_type_or_tissue_affected_by_chemical_or_drug | Which cell type or tissue is affected by the chemical or drug {subj}? | C0039195 | Cytotoxic T-Lymphocytes | C3891455 | HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c | MCPyV-LT-encoding Plasmid DNA Vaccine ITI-3000 | AdC68 Expressing PSA/PSMA/PSCA Vaccine PF-06755992 | HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c | CMVpp65/gB Plasmid Vaccine ASP0113 | 2 |
C0225336::cell_type_or_tissue_affected_by_chemical_or_drug | cell_type_or_tissue_affected_by_chemical_or_drug | Which cell type or tissue is affected by the chemical or drug {subj}? | C0225336 | Endothelial Cells | C0038880 | suramin | narasin | suramin | flibanserin | procaterol | 1 |
C0018956::cell_type_or_tissue_affected_by_chemical_or_drug | cell_type_or_tissue_affected_by_chemical_or_drug | Which cell type or tissue is affected by the chemical or drug {subj}? | C0018956 | Hematopoietic stem cells | C0210630 | filgrastim | Lipegfilgrastim only product | filgrastim | pegfilgrastim-cbqv | pegfilgrastim-jmdb | 1 |
C1174995::chemical_or_drug_has_mechanism_of_action | chemical_or_drug_has_mechanism_of_action | What is the mechanism of action of the chemical or drug {subj}? | C1174995 | efalizumab | C1148575 | antigen binding | protease binding | host cell surface receptor binding | antigen binding | IgG binding | 2 |
C1831781::chemical_or_drug_has_mechanism_of_action | chemical_or_drug_has_mechanism_of_action | What is the mechanism of action of the chemical or drug {subj}? | C1831781 | Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine | C1706823 | Antigen Sensitization | Antigen Sensitization | CD38-directed Antibody Interactions | Anthrax Protective Antigen-directed Antibody Interactions | CD86-directed Antibody Interactions | 0 |
C5432276::chemical_or_drug_has_mechanism_of_action | chemical_or_drug_has_mechanism_of_action | What is the mechanism of action of the chemical or drug {subj}? | C5432276 | Vibostolimab | C1148575 | antigen binding | IgG binding | protease binding | antigen binding | peptide antigen assembly with MHC protein complex | 2 |
C5448080::chemical_or_drug_has_physiologic_effect | chemical_or_drug_has_physiologic_effect | What physiologic effect does the chemical or drug {subj} have? | C5448080 | CDK9 Inhibitor GFH009 | C0017263 | Gene Expression Regulation | Transcriptional Regulation | Transcription, Genetic | Gene Expression Regulation | negative regulation of gene expression | 2 |
C5206651::chemical_or_drug_has_physiologic_effect | chemical_or_drug_has_physiologic_effect | What physiologic effect does the chemical or drug {subj} have? | C5206651 | Luminespib Mesylate | C1326205 | Positive Regulation of Apoptosis | Positive Regulation of Apoptosis | positive regulation of programmed cell death | negative regulation of apoptotic cell clearance | negative regulation of apoptosome assembly | 0 |
C3896843::chemical_or_drug_has_physiologic_effect | chemical_or_drug_has_physiologic_effect | What physiologic effect does the chemical or drug {subj} have? | C3896843 | hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301 | C1155065 | T-Cell Activation | B-Cell Immune Response Pathway | Negative Regulation of Lymphocyte Activation | activated T cell proliferation | T-Cell Activation | 3 |
C0023660::chemical_or_drug_is_metabolized_by_enzyme | chemical_or_drug_is_metabolized_by_enzyme | Which enzyme metabolizes the chemical or drug {subj}? | C0023660 | lidocaine | C3887685 | Cytochrome P450 2D6, human | Cytochrome p450 CYP3A43 enzyme | Cytochrome p450 CYP2R1 enzyme | Cytochrome P450 46A1 | Cytochrome P450 2D6, human | 3 |
C0546857::chemical_or_drug_is_metabolized_by_enzyme | chemical_or_drug_is_metabolized_by_enzyme | Which enzyme metabolizes the chemical or drug {subj}? | C0546857 | chlorpheniramine maleate | C1142644 | cytochrome P450 3A4 protein, human | Cytochrome p450 CYP2S1 enzyme | cytochrome P-450 CYP1B1 | cytochrome P450 3A4 protein, human | Cytochrome p450 CYP5A1 enzyme | 2 |
C0063077::chemical_or_drug_is_metabolized_by_enzyme | chemical_or_drug_is_metabolized_by_enzyme | Which enzyme metabolizes the chemical or drug {subj}? | C0063077 | hydrocortisone acetate | C1142644 | cytochrome P450 3A4 protein, human | cytochrome P-450 CYP1B1 | Cytochrome p450 CYP3A7 enzyme | Cytochrome p450 CYP2A13 enzyme | cytochrome P450 3A4 protein, human | 3 |
C0796472::chemotherapy_regimen_has_component | chemotherapy_regimen_has_component | Which of the following is a component of the chemotherapy regimen {subj}? | C0796472 | Amifostine/Carboplatin/Etoposide/Ifosfamide | C0015020 | amifostine | febuxostat | dalfampridine | amifostine | feprazone | 2 |
C0879517::chemotherapy_regimen_has_component | chemotherapy_regimen_has_component | Which of the following is a component of the chemotherapy regimen {subj}? | C0879517 | Celecoxib/Selenium | C0036581 | selenium | sodium selenate | chromium | selenium | trace elements with selenium | 2 |
C0280675::chemotherapy_regimen_has_component | chemotherapy_regimen_has_component | Which of the following is a component of the chemotherapy regimen {subj}? | C0280675 | Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine | C0008838 | cisplatin | Cisplatin liposome | Carboplatin only product | Citoplatino | cisplatin | 3 |
C0008655::chromosome_involved_in_cytogenetic_abnormality | chromosome_involved_in_cytogenetic_abnormality | Which chromosome is involved in the cytogenetic abnormality {subj}? | C0008655 | Chromosomes, Human, Pair 13 | C1515583 | del(13q21-qter) | Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 | Chromosome 3, monosomy 3q13 | del(13q21-qter) | Chromosome 14q, partial deletions | 2 |
C0008665::chromosome_involved_in_cytogenetic_abnormality | chromosome_involved_in_cytogenetic_abnormality | Which chromosome is involved in the cytogenetic abnormality {subj}? | C0008665 | Chromosomes, Human, Pair 22 | C5420426 | NF2 Gene Deletion | ARID2 Gene Mutation | NF1 Gene Mutation | Deleterious NBN Gene Mutation | NF2 Gene Deletion | 3 |
C0008652::chromosome_involved_in_cytogenetic_abnormality | chromosome_involved_in_cytogenetic_abnormality | Which chromosome is involved in the cytogenetic abnormality {subj}? | C0008652 | Chromosomes, Human, Pair 10 | C5238354 | t(10;11)(p12.1;q23.3) | PML/RAR alpha (t(15;17)) gene expression | Chromosome region Xp22.33 &or Yp11.32 deletion+duplication | t(10;11)(p12.1;q23.3) | 1p & 19q chromosome deletion | 2 |
C0021034::complex_has_physical_part | complex_has_physical_part | Which of the following is a physical part of the complex {subj}? | C0021034 | Immunoglobulin Heavy Chains | C5444093 | Immunoglobulin Heavy Constant Mu | Immunoglobulin E antigen | Immunoglobulin M | Linen Antibody.immunoglobulin E | Immunoglobulin Heavy Constant Mu | 3 |
C0033384::complex_has_physical_part | complex_has_physical_part | Which of the following is a physical part of the complex {subj}? | C0033384 | Procollagen-Proline Dioxygenase | C3542409 | Prolyl 4-Hydroxylase Subunit Alpha-2 | Dihydrolipoyllysine-Residue Succinyltransferase Component of 2-Oxoglutarate Dehydrogenase Complex, Mitochondrial | Prolyl 4-Hydroxylase Subunit Alpha-2 | Sterol 26-Hydroxylase, Mitochondrial, Human | 3 Beta-Hydroxysteroid Dehydrogenase/Delta 5-->4-Isomerase Type 2, human | 1 |
C4723818::complex_has_physical_part | complex_has_physical_part | Which of the following is a physical part of the complex {subj}? | C4723818 | Canonical BAF Complex | C1332367 | SMARCE1 protein, human | SORT1 protein, human | SMARCE1 protein, human | SCARB1 protein, human | ASAP1 protein, human | 1 |
C0010711::component_of | component_of | Which of the following contains {subj} as a component? | C0010711 | cytarabine | C0280710 | Asparaginase/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine | Cyclophosphamide/Epirubicin/Vincristine Regimen | Cyclophosphamide/Daunorubicin/Dexamethasone/Pegaspargase/Vincristine Regimen | Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/R-Verapamil | Asparaginase/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine | 3 |
C0108754::component_of | component_of | Which of the following contains {subj} as a component? | C0108754 | CD56 Antigens | C5188572 | CD3-CD16+CD56+ cells in unspecified specimen | CD45 cells per 100 cells in blood | CD20 Cells/100 Cells in Unspecified Specimen | CD3-CD16+CD56+ cells in unspecified specimen | B-cell CD27 & IgD subsets panel | 2 |
C0002520::component_of | component_of | Which of the following contains {subj} as a component? | C0002520 | Amino Acids | C0546747 | Amino acid chromatography | Ultracentrifugation | Amino acid chromatography | Acid fast stain (procedure) | Analysis using protein truncation test | 1 |
C0000970::contained_in | contained_in | Which of the following contains {subj}? | C0000970 | acetaminophen | C2080494 | acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine | atropine / chlorpheniramine / phenylephrine / phenyltoloxamine | dexbrompheniramine / dextromethorphan / guaifenesin / phenylephrine | acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine | chlorpheniramine / guaifenesin / phenylpropanolamine / pseudoephedrine | 2 |
C0028356::contained_in | contained_in | Which of the following contains {subj}? | C0028356 | norethindrone | C5455339 | estradiol / norethindrone / relugolix | Relugolix / Estradiol / Norethindrone Acetate | Drospirenone and estradiol only product | estradiol / norethindrone / relugolix | dienogest / ethinyl estradiol | 2 |
C0033798::contained_in | contained_in | Which of the following contains {subj}? | C0033798 | pseudoephedrine | C2929162 | brompheniramine / dextromethorphan / guaifenesin / pseudoephedrine | chlorpheniramine + dextromethorphan + terpin hydrate | chlorpheniramine + sodium salicylate + caffeine + dextromethorphan + guaifenesin | brompheniramine / dextromethorphan / guaifenesin / pseudoephedrine | brompheniramine / guaifenesin / phenylephrine | 2 |
C0717396::contains | contains | Which of the following is contained in {subj}? | C0717396 | aluminum hydroxide / mineral oil | C0002371 | aluminum hydroxide | aluminum hydroxide / magnesium trisilicate | aluminum hydroxide | magnesium carbonate hydroxide | aluminum hydroxide / silicon dioxide | 1 |
C0230147::contains | contains | Which of the following is contained in {subj}? | C0230147 | Superior mediastinum | C0925190 | T4 segment of esophagus | T4 segment of esophagus | Segment of esophagus | Aortic narrowing of esophagus | Structure of esophageal gland | 0 |
C2080527::contains | contains | Which of the following is contained in {subj}? | C2080527 | acetaminophen / diphenhydramine / guaifenesin / phenylephrine | C0000970 | acetaminophen | acetaminophen / dimenhydrinate | acetaminophen | acetaminophen / piroxicam | acetaminophen / styramate | 1 |
C3883272::contraindicated_class_of | contraindicated_class_of | For which class is {subj} contraindicated? | C3883272 | dasabuvir sodium monohydrate | C0073633 | ranolazine | profenamine | robenidine | ranolazine | vinburnine | 2 |
C0286738::contraindicated_class_of | contraindicated_class_of | For which class is {subj} contraindicated? | C0286738 | saquinavir | C0012291 | dihydroergotamine | dehydroemetine | dihydroergotamine | dihydroergotoxine | Dihydroergotamine only product in nasal dose form | 1 |
C5540070::contraindicated_class_of | contraindicated_class_of | For which class is {subj} contraindicated? | C5540070 | samidorphan L-malate | C0242402 | Opioids | Pharmagesic | Opioids | Sedatives | Percogesic | 1 |
C0030830::contraindicated_with_disease | contraindicated_with_disease | Which disease contraindicates the use of {subj}? | C0030830 | penicillin G procaine | C0013182 | Drug Allergy | Allergy to topical drugs | Drug Allergy | Allergy to horse protein | Allergy to seed | 1 |
C0851344::contraindicated_with_disease | contraindicated_with_disease | Which disease contraindicates the use of {subj}? | C0851344 | exemestane | C0013182 | Drug Allergy | Allergy to chemicals | Allergy to fungus | Drug Allergy | Allergy to plant | 2 |
C1883309::contraindicated_with_disease | contraindicated_with_disease | Which disease contraindicates the use of {subj}? | C1883309 | thioguanine anhydrous | C0032961 | Pregnancy | Septuplet pregnancy | Pregnancy | Single pregnancy | Mullerian duct regression | 1 |
C5419220::cytogenetic_abnormality_involves_chromosome | cytogenetic_abnormality_involves_chromosome | Which chromosome is involved in the cytogenetic abnormality {subj}? | C5419220 | Rearrangement of 12p13.2 | C0008654 | Chromosomes, Human, Pair 12 | Chromosomes, Human, 21-22 and Y | Chromosomes, Human, Pair 12 | condensed chromosome, centromeric region | Chromosomes, Human, 13-15 | 1 |
C1515648::cytogenetic_abnormality_involves_chromosome | cytogenetic_abnormality_involves_chromosome | Which chromosome is involved in the cytogenetic abnormality {subj}? | C1515648 | i(17q) | C0008659 | Chromosomes, Human, Pair 17 | polytene chromosome chromocenter | chromosome, centromeric region | Chromosomes | Chromosomes, Human, Pair 17 | 3 |
C5446674::cytogenetic_abnormality_involves_chromosome | cytogenetic_abnormality_involves_chromosome | Which chromosome is involved in the cytogenetic abnormality {subj}? | C5446674 | CHIC2 Gene Deletion | C0008667 | Chromosomes, Human, Pair 4 | chromosome, telomeric repeat region | Chromosome Territory | Chromosomes, Human, Pair 4 | Chromosome band | 2 |
C0018099::default_inpatient_classification_of | default_inpatient_classification_of | For which of the following is {subj} the default inpatient classification? | C0018099 | Gout | C2894121 | Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi) | chronic gout of foot without tophus due to renal impairment | Chronic gout of elbow without tophus caused by drug | Primary chronic gout without tophus of vertebra | Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi) | 3 |
C0024305::default_inpatient_classification_of | default_inpatient_classification_of | For which of the following is {subj} the default inpatient classification? | C0024305 | Lymphoma, Non-Hodgkin | C2853810 | Follicular Lymphoma Grade III, Unspecified, Lymph Nodes of Axilla and Upper Limb | Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | Follicular Lymphoma Grade III, Unspecified, Lymph Nodes of Axilla and Upper Limb | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | 1 |
C5225826::default_inpatient_classification_of | default_inpatient_classification_of | For which of the following is {subj} the default inpatient classification? | C5225826 | Pressure ulcer of skin | C2888559 | Pressure injury of right heel stage IV | Pressure injury of right heel stage IV | Pressure injury of right lower leg stage IV | Pressure injury of left foot stage II | Pressure injury of right foot stage III | 0 |
C5225867::default_outpatient_classification_of | default_outpatient_classification_of | For which of the following is {subj} the default outpatient classification? | C5225867 | Crystal arthropathies (excluding gout) | C2893561 | familial chondrocalcinosis wrist | familial chondrocalcinosis wrist | chondrocalcinosis of foot | familial chondrocalcinosis hip | chondrocalcinosis of hip | 0 |
C4041080::default_outpatient_classification_of | default_outpatient_classification_of | For which of the following is {subj} the default outpatient classification? | C4041080 | Neurocognitive Disorders | C5674995 | mild neurocognitive disorder due to known physiological condition with behavioral disturbance | Mental and behavioral disorders due to use of cannabinoids, withdrawal state with delirium | mild neurocognitive disorder due to known physiological condition with behavioral disturbance | Severe mental retardation with the statement of no, or minimal, impairment of behavior | Other mental retardation without mention of impairment of behavior | 1 |
C5225999::default_outpatient_classification_of | default_outpatient_classification_of | For which of the following is {subj} the default outpatient classification? | C5225999 | Complication of genitourinary device, implant or graft, subsequent encounter | C4270236 | Other mechanical complication of indwelling urethral catheter, subsequent encounter | Obstruction of urethral urinary catheter | inflammatory reaction due to indwelling urinary catheter | mechanical complication of urinary electronic stimulator device breakdown | Other mechanical complication of indwelling urethral catheter, subsequent encounter | 3 |
C3469128::defining_characteristic_of | defining_characteristic_of | For which of the following is {subj} a defining characteristic? | C3469128 | personal growth | C0018235 | Grief reaction | Excitedness | Conscious mind | Overlearning | Grief reaction | 3 |
C4061436::defining_characteristic_of | defining_characteristic_of | For which of the following is {subj} a defining characteristic? | C4061436 | Excessive self-blame | C4060542 | Impaired mood regulation | Impaired mood regulation | Executive dysfunction | Alteration in memory | Impaired psychomotor development | 0 |
C0242528::defining_characteristic_of | defining_characteristic_of | For which of the following is {subj} a defining characteristic? | C0242528 | Azotemia | C0546817 | Hypervolemia (finding) | Dilutional hyponatremia | Hypervolemia (finding) | Hypovolemic Shock | Lymphedema (lower limb) | 1 |
C0013182::definitional_manifestation_of | definitional_manifestation_of | For which of the following is {subj} a definitional manifestation? | C0013182 | Drug Allergy | C0571315 | Anti-infective nasal preparations allergy | Allergy to food additive | Allergic rhinitis caused by feathers | Anti-infective nasal preparations allergy | Allergic rhinitis due to food | 2 |
C0221395::definitional_manifestation_of | definitional_manifestation_of | For which of the following is {subj} a definitional manifestation? | C0221395 | Erythropenia | C2919522 | Congenital hemolytic uremic syndrome | Familial Atypical Hemolytic Uremic Syndrome | Congenital uremia | Congenital methemoglobinemia (due to enzyme deficiency) | Congenital hemolytic uremic syndrome | 3 |
C0349231::definitional_manifestation_of | definitional_manifestation_of | For which of the following is {subj} a definitional manifestation? | C0349231 | Phobic anxiety disorder | C0270587 | Generalized social phobia | Generalized social phobia | Inhalant-induced psychotic disorder with delusions | animal type phobia | Psychotic disorder caused by anxiolytic | 0 |
C0332996::direct_morphology_of | direct_morphology_of | Which of the following has {subj} as its direct morphology? | C0332996 | Persistent embryonic structure | C0198511 | Excision of omphalomesenteric duct | Excision of thyroglossal tract | Excision of omphalomesenteric duct | Excision of colonic pouch | Incision of mesentery | 1 |
C0559494::direct_morphology_of | direct_morphology_of | Which of the following has {subj} as its direct morphology? | C0559494 | Intestinal stoma | C0192810 | Dilation of intestinal stoma | dilation of ileum with intraluminal device | Jejunoscopy and insertion of tube prosthesis | Creation of proctostomy | Dilation of intestinal stoma | 3 |
C5848091::direct_morphology_of | direct_morphology_of | Which of the following has {subj} as its direct morphology? | C5848091 | Viral wart of skin and/or mucous membrane caused by human papillomavirus | C2959416 | Cauterization of wart of pinna | Cauterization of forefoot | Drainage of petrous apex of mastoid | Cauterization of external ear | Cauterization of wart of pinna | 3 |
C0031354::direct_procedure_site_of | direct_procedure_site_of | Which procedure directly targets the site {subj}? | C0031354 | Pharyngeal structure | C0192253 | Transplantation of pharyngeal tissue | Laryngeal reinnervation by neuromuscular pedicle | Injection of neurolytic substance to glossopharyngeal nerve | Transplantation of pharyngeal tissue | Reconstruction of zygomatic arch and glenoid fossa with bone and cartilage (includes obtaining autografts) | 2 |
C1276274::direct_procedure_site_of | direct_procedure_site_of | Which procedure directly targets the site {subj}? | C1276274 | Structure of soft tissues of neck | C2153057 | soft tissue mobilization of anterior aspect of neck | scar tissue mobilization of deltoid region of right shoulder | scar tissue mobilization of right thigh | scar tissue mobilization of left anterior aspect of chest | soft tissue mobilization of anterior aspect of neck | 3 |
C0225066::direct_procedure_site_of | direct_procedure_site_of | Which procedure directly targets the site {subj}? | C0225066 | Collateral ulnar ligament of elbow | C4277652 | Ulnar Collateral Ligament Reconstruction | Open treatment of distal tibiofibular joint (syndesmosis) disruption, includes internal fixation, when performed | Open treatment of tarsometatarsal joint dislocation, includes internal fixation, when performed | closed treatment of humeral greater tuberosity fracture | Ulnar Collateral Ligament Reconstruction | 3 |
C0334498::disease_excludes_abnormal_cell | disease_excludes_abnormal_cell | Which abnormal cell type is specifically excluded in the definition of the disease {subj}? | C0334498 | Serous adenofibroma | C1518246 | Malignant Stromal Cell | Malignant Cutaneous Basal Cell | Malignant Squamoid Cell | Neoplastic Melanocyte | Malignant Stromal Cell | 3 |
C1336013::disease_excludes_abnormal_cell | disease_excludes_abnormal_cell | Which abnormal cell type is specifically excluded in the definition of the disease {subj}? | C1336013 | Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene | C0085133 | Reed-Sternberg Cells | Leukemic Natural Killer Cell | Reed-Sternberg Cells | Epithelioid Cells | Spindle Melanocyte | 1 |
C1711320::disease_excludes_abnormal_cell | disease_excludes_abnormal_cell | Which abnormal cell type is specifically excluded in the definition of the disease {subj}? | C1711320 | signet ring cell carcinoma of appendix | C1514101 | Neoplastic Squamous Cell | Neoplastic Myoepithelial Cell | Undifferentiated Neoplastic Blast | Neoplastic Melanocyte | Neoplastic Squamous Cell | 3 |
C4744758::disease_excludes_cytogenetic_abnormality | disease_excludes_cytogenetic_abnormality | Which cytogenetic abnormality is specifically excluded in the disease {subj}? | C4744758 | Thyroid Gland Lymphangioma | C1517995 | Loss of Chromosome 9q | Loss of Chromosome 1q | Loss of Chromosome 4q | Loss of Chromosome 17p | Loss of Chromosome 9q | 3 |
C5206834::disease_excludes_cytogenetic_abnormality | disease_excludes_cytogenetic_abnormality | Which cytogenetic abnormality is specifically excluded in the disease {subj}? | C5206834 | Benign Parapharyngeal Neoplasm | C1517995 | Loss of Chromosome 9q | Loss of Chromosome 22q | Loss of Chromosome 6p | Loss of Chromosome 8p | Loss of Chromosome 9q | 3 |
C2826148::disease_excludes_cytogenetic_abnormality | disease_excludes_cytogenetic_abnormality | Which cytogenetic abnormality is specifically excluded in the disease {subj}? | C2826148 | Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy | C1515809 | t(9;22)(q34.1;q11.2) | t(10;11)(q21.3;q23.3) | t(9;22)(q34.1;q11.2) | t(2;22)(q33.3;q12) | t(11;19)(q23.3;p13.3) | 1 |
C4727078::disease_excludes_finding | disease_excludes_finding | Which finding is specifically excluded in the diagnosis of disease {subj}? | C4727078 | Advanced Synovial Sarcoma | C0277565 | Local disease | Severe infection | Local disease | Soft tissue swelling | Tumour inflammation | 1 |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 41